The Curaleaf Access Scheme provides reduced clinical review costs for patients who contribute to Curaleaf’s evidence platform, the UK Medical Cannabis Registry. This allows patients to access the same high quality care, whilst also contributing their anonymous data to growing the evidence base of medical cannabis in the UK.